1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3-(2-hydroxyethyl)-3-nitrosourea
Also known as: - Nitrosamine Impurities or nitrosamine impurities of -| Product Name | 1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3-(2-hydroxyethyl)-3-nitrosourea |
|---|---|
| Alternate Names | - Impurities, Impurities of - |
| CAT No. | CS-O-44380 |
| CAS No. | 89854-43-3 |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 243.18 g/mol |
| Mol. For. | C7H9N5O5 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3-(2-hydroxyethyl)-3-nitrosourea is a chemical compound that is used in the medical field as an alkylating agent in chemotherapy. It is commonly referred to as DTIC (Dacarbazine) and is used to treat various types of cancer, such as melanoma and Hodgkin's lymphoma.
The chemical structure of DTIC consists of a nitrosourea functional group, which is known for its ability to alkylate DNA and RNA. This process leads to the formation of covalent bonds between the drug and the nucleic acid, which ultimately results in the inhibition of DNA synthesis and cell division. The pyrimidine ring in the molecule also contributes to the cytotoxicity of the drug by inducing DNA damage.
DTIC is administered intravenously and is rapidly metabolized in the liver to its active form. The drug is eliminated from the body through the kidneys and has a short half-life of approximately 20 minutes.
While DTIC is an effective chemotherapy drug, it does have side effects, including nausea, vomiting, and myelosuppression (a decrease in blood cell production). However, these side effects can be managed through supportive care and dose adjustments.
In conclusion, 1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3-(2-hydroxyethyl)-3-nitrosourea, or DTIC, is a chemical compound used in chemotherapy to treat cancer. Its mechanism of action involves the alkylation of DNA and RNA, ultimately leading to the inhibition of cell division. While it does have side effects, it remains an important tool in the fight against cancer.
Get an Instant Quote
Related Compounds
Ciclosporin impurity (NAP 005-95) | Demethyloleuropein Aglycone | Resmetirom Impurity 8 | Bromocriptine EP Impurity D | Tandospirone Citrate Impurity I | Enzalutamide N-Ethyl Impurity | Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside | N2',N2'''-[Dithiobis(1-oxo-3,1-propanediyl)]bis[N2'-deacetyl-maytansine | N-Nitroso Decyl Aminoquat | PEG-8 Laurate | Aminodihexylquat Nitroso Impurity | Dehydro Finerenone | Lithium ((3-(methacryloyloxy)propyl)sulfonyl)((trifluoromethyl)sulfonyl)amide | Fluorouracil Impurity 11 | Atorvastatin Impurity D ( Mixture of compounds ) | N-Nitroso-N-methylcyclohexylamine 1mg/ml in MeOH | Polybutylene terephthalate Impurity 1 | Adrenalin Nitroso Impurity 1 | N-(4H-1,2,4-triazol-4-yl)nitrous amide | Polybutylene terephthalate Impurity 2 | N-formimidoylthienamycin Impurity | Diethoxyethane | Guaiacol allyl ether | N-(4-amino-3-methoxyphenyl)-N-hydroxy methanesulfonamide | Tri-p-tolyl Phosphite | Samidorphan methanobenzofuron isoquinoline | N-Nitroso Venetoclax intermediate( VNL6) | Nimodipine Impurity 6 | Dextrates monohydrate | Ouratea proanthocyanidin A | Sugammadex Octa sulfone | Cadmium Hydroxide | Cevimeline disulfide dimer | Benzene,1,2-Dichloro-3-(dibromomethyl) | methyl 2,4-dichloro-3-oxopentanoate | Fidaxomicin Related Compound L | Fmoc-Val-Ser[Psi(Me,Me)Pro]-OH | N-Methyl-N-(4-methylphenyl)nitrous Amide | Piperacillin Impurity I | Chlordiazepoxide oxaziridine | Torulene | Nintedanib Impurity 63 | Enpp1-IN-3 | Paroxetine Impurity | Trimethylolpropane ethoxy triacrylate | Efavirenz Descarbonyl Benzyl impurity | Nonylphenol | N,S-(Dicarboxymethyl)cysteine | N-(Benzo[d]isoxazol-3-yl)-N-methylmethanesulfonamide | ethyl 7-((5-methyl-4,4-dioxido-5,10-dihydrobenzo[c]thieno[2,3-f][1,2]thiazepin-10-yl)amino)heptanoate | Isoquinoline-4,6-diol | Heptacarboxylporphyrin I Dihydrochloride | sodium (2-((1R,3S,4aS,4bS,10aS,10bR,11S,12aS)-10b-fluoro-1,11-dihydroxy-3,10a,12a-trimethyl-2,8-dioxo-1,2,3,4,4a,4b,5,6,8,10a,10b,11,12,12a-tetradecahydrochrysen-1-yl)ethyl)phosphonate | Nandrolone hydrogen succinate | GLP-0492-13C,d3 | Lumefantrine Hydroxy impurity (Mixture of Isomers) | Nandrolone cyclohexylpropionate | Ulinastatin JP Reference standard (3700 units) | cis-1-Phenyl-2-propionylcyclopropane | Methyl 4-chloro-3-oxopentanoate | Hydrocortisone Impurity - 18 | Larotrectinib (3R,2R) Sulfate | Oxo(OtBu)-γ-Glu(α-OtBu)-AEEA-OH | N-benzyl-4-methylpyridinium chloride | diethyl 2-(((3-chlorophenyl)(nitroso) amino)methylene)malonate | N-(4-(3-ethoxy-2-hydroxypropoxy)phenyl)acrylamide | N-Nitroso Didecylamine (Mixture of Isomers) | Dioctyl Carbonate | Ethyl (R)-3-(3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanamido)propanoate | Potassium 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoate |